Kiniksa Pharmaceuticals International, plc (KNSA) › Total LiabilitiesKiniksa Pharmaceuticals International, plc (KNSA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $17.43M2018: $42.70M2019: $29.11M2020: $37.53M2021: $47.76M2022: $63.52M2023: $87.48M2024: $142.12M2025: $196.03M$196.03M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$196.03M+37.9%2024$142.12M+62.5%2023$87.48M+37.7%2022$63.52M+33.0%2021$47.76M+27.3%2020$37.53M+28.9%2019$29.11M-31.8%2018$42.70M+145.0%2017$17.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share